Free Multistate Pharmacy Jurisprudence MCQ Questions and Answers — Questions and Answers
Question 1: What is the primary goal of a new drug's Phase 3 clinical trial?
- To determine the adverse effects and proper dosage
- To evaluate the drug's safety on laboratory animals
- To determine whether the drug can be safely given to humans
- To determine the drug's effectiveness versus the effectiveness of a placebo (Correct answer)
- To assess the marketability of the drug
Correct answer: To determine the drug's effectiveness versus the effectiveness of a placebo
Large patient populations are included in phase 3 trials, often using double-masked techniques. The primary goal is to compare the effectiveness of the medication to that of a placebo-treated control group of patients.
Question 2: What is the name of a drug created primarily to address a rare medical condition?
- Targeted drug
- Orphan drug (Correct answer)
- Type N drug
- Type 3 drug
- Subsidized drug
Correct answer: Orphan drug
Orphan medications are prescribed for uncommon disorders affecting fewer than 200,000 Americans—the Orphan Drug Act of 1983 aims to motivate businesses to provide medicines for specific illnesses.
Question 3: What is the proper sequencing for the three NDC code segments?
- Product Segment, Labeler Code, Package Segment
- Package Segment, Labeler Code, Product Segment
- Package Segment, Product Segment, Labeler Code
- Labeler Code, Package Segment, Product Segment
- Labeler Code, Product Segment, Package Segment (Correct answer)
Correct answer: Labeler Code, Product Segment, Package Segment
Each drug has a unique 10-digit identification code called the NDC. There are three sections: The labeler code indicates the business that makes or sells the medication. The strength, dosing form, and formulation are specified in the Product section. The size and shape of the package are specified in the Package section.
Question 4: Despite not being utilized to treat a condition that poses a serious threat to life, a medicine is discovered to be inadequate. What kind of recall is necessary?
- No recall will be required
- Class I
- Class II (Correct answer)
- Class III
- Class IV
Correct answer: Class II
Products that are unsafe or flawed and may result in significant injury are subject to Class I recalls. Recalls under Class II are made for goods that might momentarily harm consumers' health. Products unlikely to cause any health issues are subject to Class III recalls.
Question 5: Who is the legitimate owner of a prescription once it has been filled and administered?
- The customer
- The pharmacist
- The pharmacy (Correct answer)
- The state board of pharmacy
- The prescription must be shredded immediately
Correct answer: The pharmacy
It is legally owned by the pharmacy and should not be given to the patient. A copy of the prescription should be offered if the patient requests it.
Question 6: The following conditions must be met, except one, for a medicine to be declared pharmaceutically equivalent.
- Same dosage form
- Identical amounts of the same active ingredient
- Identical strength or concentration
- Same route of administration
- Same exipients (Correct answer)
Correct answer: Same exipients
The excipient and active components don't need to be identical for a medicine to be considered a pharmacological equivalent.
Question 7: Based on research findings, there is proof that a new medicine may endanger the development of a human fetus. Despite these potential concerns, the drug's advantages can make it appropriate during pregnancy. Which pregnancy category would this medication fall under?
- Category B
- Category A
- Category D (Correct answer)
- Category C
- Category X
Correct answer: Category D
The most risky medications for pregnant women are those in Category X, whereas Category A pharmaceuticals are the safest.
Free Multistate Pharmacy Jurisprudence MCQ Questions and Answers
What is the primary goal of a new drug's Phase 3 clinical trial?